サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463640

中南米の大動脈弁置換用デバイス：2030年までの市場予測 - 地域分析 - 製品別、手術別、エンドユーザー別

South & Central America Aortic Valve Replacement Devices Market Forecast to 2030 - Regional Analysis - by Product, Surgery, and End User

出版日
ページ情報
英文 83 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
中南米の大動脈弁置換用デバイス：2030年までの市場予測 - 地域分析 - 製品別、手術別、エンドユーザー別
出版日: 2024年01月24日
発行: The Insight Partners
ページ情報: 英文 83 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の大動脈弁置換用デバイス市場は、2022年の3億6,563万米ドルから2030年には8億7,641万米ドルに成長すると予測されています。2022年から2030年までのCAGRは11.5%と推定されます。

大動脈弁置換用デバイスの進歩が中南米の大動脈弁置換用デバイス市場を後押し

経カテーテル大動脈弁置換術（TAVR）などの低侵襲手術手技（MIS）の開発は、大動脈弁狭窄症（AS）の治療を近代化しました。経カテーテル的大動脈弁置換術は、従来の開心術よりも侵襲が少ないため、これまで手術の対象とならなかったような高リスクの患者でも治療を受けられるようになった。さらに、材料やデザインの開発により、より丈夫で生体適合性の高い大動脈弁置換術が開発され、患者の予後が改善され、合併症のリスクも減少しています。

大動脈弁置換用デバイスのプレーヤーによるいくつかの技術的進歩を以下に挙げる：

2023年1月、アボット社は、開心術のリスクが高い重度の大動脈弁狭窄症の患者を治療するための経カテーテル大動脈弁留置（TAVI）システム「ナビトール」のFDA承認を取得しました。ナビトールはアボット社の広範な経カテーテル構造心臓ポートフォリオに加わった最新の製品であり、様々な重篤な心臓病に対してより侵襲の少ない治療オプションを医師と患者に提供するものです。

2021年9月、アボットは大動脈弁や僧帽弁疾患の患者に対する治療選択肢を改善するため、Epic PlusおよびEpic Plus Supra Stented Tissue ValvesのFDA承認を取得しました。この新しい装置により、アボットはエピック外科弁プラットフォームを拡大しました。

したがって、技術的進歩は大動脈弁置換用デバイス市場に有利な機会を生み出しています。

中南米の大動脈弁置換用デバイス市場概要

中南米の大動脈弁置換用デバイス市場は、ブラジル、アルゼンチン、その他中南米に区分されます。同地域の市場は、大動脈弁狭窄症の有病率の急増、弁置換手術に関する認知度を高めるための様々な政府組織による取り組みにより成長が見込まれています。

中南米の大動脈弁置換用デバイス市場の収益と2030年までの予測（金額）

中南米の大動脈弁置換用デバイス市場セグメンテーション

中南米の大動脈弁置換用デバイス市場は、製品、手術、エンドユーザー、国別にセグメント化されています。

製品別では、中南米の大動脈弁置換用デバイス市場は無縫合弁と機械式弁にセグメント化されます。2022年の中南米の大動脈弁置換用デバイス市場は、無縫合弁が大きなシェアを占めています。

手術に基づき、中南米の大動脈弁置換用デバイス市場は低侵襲手術と開腹手術にセグメント化されます。低侵襲手術セグメントは、2022年に中南米の大動脈弁置換用デバイス市場でより大きなシェアを占めました。

エンドユーザー別では、中南米の大動脈弁置換用デバイス市場は病院＆クリニック、外来手術センター、その他に区分されます。病院＆クリニックセグメントが2022年の中南米の大動脈弁置換用デバイス市場シェアで最大を占めました。

国別では、中南米の大動脈弁置換用デバイス市場は、ブラジル、アルゼンチン、その他中南米に分類されています。ブラジルは2022年の中南米の大動脈弁置換用デバイス市場シェアを独占しました。

Abbott Laboratories、Medtronic Plc、Boston Scientific Corp、LivaNova Plc、Edwards Lifesciences Corp、Braile Biomedica Industry、Commerce and Representations Ltd、Artivion Inc、Venus MedTech HangZhou Inc、Labcor Laboratorios Ltda。などが大動脈弁置換用デバイス市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の大動脈弁置換用デバイス市場情勢

  • 概観
  • PEST分析
    • 中南米のPEST分析

第5章 中南米の大動脈弁置換用デバイス市場：主要産業力学

  • 主な市場促進要因
    • 大動脈弁置換手術件数の増加
    • 低侵襲技術への需要の高まり
  • 市場抑制要因
    • 製品リコール
    • 心臓構造装置に関する厳しい規制
  • 市場機会
    • 大動脈弁置換用デバイスの進歩
  • 今後の動向
    • 臨床研究の増加
  • 影響分析

第6章 大動脈弁置換用デバイス市場：中南米市場分析

  • 中南米の大動脈弁置換用デバイス市場収益、2022年～2030年

第7章 大動脈弁置換用デバイス市場 - 収益と2030年までの予測：製品別

  • 中南米の大動脈弁置換用デバイス市場：2022年・2030年製品別収益シェア（%）
  • メカニカルバルブ
  • 無縫合弁

第8章 中南米の大動脈弁置換用デバイス市場 - 収益と2030年までの予測：手術別

  • 中南米の大動脈弁置換用デバイス市場：2022年・2030年手術別収益シェア（%）
  • 開腹手術
  • 低侵襲手術

第9章 中南米の大動脈弁置換用デバイス市場 - 収益と2030年までの予測：エンドユーザー別

  • 中南米の大動脈弁置換用デバイス市場：2022年・2030年エンドユーザー別収益シェア（%）
  • 病院・診療所
  • 外来手術センター
  • その他

第10章 中南米の大動脈弁置換用デバイス市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 大動脈弁置換用デバイスの世界市場：業界情勢

  • 中南米の大動脈弁置換用デバイス市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 主要企業プロファイル

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • LivaNova Plc
  • Edwards Lifesciences Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Artivion Inc
  • Venus MedTech HangZhou Inc
  • Labcor Laboratorios Ltda.

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America Aortic Valve Replacement Devices Market Segmentation
  • Table 2. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 4. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 5. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 6. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 7. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 8. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 9. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 10. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Recent Organic Growth Strategies in Aortic Valve Replacement Devices Market
  • Table 12. Recent Inorganic Growth Strategies in the Aortic Valve Replacement Devices Market
  • Table 13. Glossary of Terms, Aortic Valve Replacement Devices Market

List Of Figures

  • Figure 1. South & Central America Aortic Valve Replacement Devices Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Aortic Valve Replacement Devices Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery 2022 & 2030 (%)
  • Figure 10. Open Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 13. Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Aortic Valve Replacement Devices Market, By country, 2022 ($Mn)
  • Figure 17. South & Central America Aortic Valve Replacement Devices Market, By Key Countries, 2022 and 2030 (%)
  • Figure 18. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 19. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 20. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. Growth Strategies in South & Central America Aortic Valve Replacement Devices Market
目次
Product Code: BMIRE00029441

The South & Central America aortic valve replacement devices market is expected to grow from US$ 365.63 million in 2022 to US$ 876.41 million by 2030. It is estimated to grow at a CAGR of 11.5% from 2022 to 2030.

Advancements in Aortic Valve Replacement Devices Fuels South & Central America Aortic Valve Replacement Devices Market

The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.

In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.

Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.

South & Central America Aortic Valve Replacement Devices Market Overview

The South & Central America aortic valve replacement devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the surge in prevalence of aortic stenosis, initiatives undertaken by various government organizations to create awareness about valve replacement surgeries.

South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Aortic Valve Replacement Devices Market Segmentation

The South & Central America aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the South & Central America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger South & Central America aortic valve replacement devices market share in 2022.

Based on surgery, the South & Central America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger South & Central America aortic valve replacement devices market share in 2022.

Based on end user, the South & Central America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest South & Central America aortic valve replacement devices market share in 2022.

Based on country, the South & Central America aortic valve replacement devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America aortic valve replacement devices market share in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, Venus MedTech HangZhou Inc, and Labcor Laboratorios Ltda. , are some of the leading companies operating in the aortic valve replacement devices market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Aortic Valve Replacement Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Aortic Valve Replacement Devices Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Rising Number of Aortic Valve Replacement Surgeries
    • 5.1.2 Increasing Demand for Minimally Invasive Techniques
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Aortic Valve Replacement Devices
  • 5.4 Future Trends
    • 5.4.1 Increasing Number of Clinical Studies
  • 5.5 Impact Analysis:

6. Aortic Valve Replacement Devices Market - South & Central America Market Analysis

  • 6.1 South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Mechanical Valve
    • 7.3.1 Overview
    • 7.3.2 Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Sutureless Valve
    • 7.4.1 Overview
    • 7.4.2 Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Surgery.

  • 8.1 Overview
  • 8.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
  • 8.3 Open Surgery
    • 8.3.1 Overview
    • 8.3.2 Open Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Minimally Invasive Surgery
    • 8.4.1 Overview
    • 8.4.2 Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by End User.

  • 9.1 Overview
  • 9.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals & Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgery Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Aortic Valve Replacement Devices Market - Country Analysis

  • 10.1 South & Central America Aortic Valve Replacement Devices Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 South & Central America Aortic Valve Replacement Devices Market by Country
      • 10.1.2.1 Brazil
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Brazil Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.1.4 Brazil Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.1.5 Brazil Aortic Valve Replacement Devices Market, by End-User
      • 10.1.2.2 Argentina
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Argentina Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.2.4 Argentina Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.2.5 Argentina Aortic Valve Replacement Devices Market, by End-User
      • 10.1.2.3 Rest of South & Central America
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Rest of South & Central America Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.3.4 Rest of South & Central America Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.3.5 Rest of South & Central America Aortic Valve Replacement Devices Market, by End-User

11. Global Aortic Valve Replacement Devices Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in South & Central America Aortic Valve Replacement Devices Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Key Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 LivaNova Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Braile Biomedica Industry, Commerce and Representations Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Artivion Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Venus MedTech HangZhou Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Labcor Laboratorios Ltda.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms